Dr. Albert Friesen reports

MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 26, 2024 CALL AT 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2024 AND ANNOUNCES RESIGNATION OF BOARD MEMBER

Medicure Inc. will present the 2024 Q3 financial results on a conference call on Nov. 26, 2024, at 8:30 a.m. Eastern Time. The Q3 financials will be filed after closing Nov. 25, 2024.

Medicure also announced today that Kimberly Kramchynsky, a member of the board of directors, has resigned for personal reasons, effective Nov. 18, 2024.

"On behalf of the board and senior leadership team, I would like to thank Kim for her contributions and voice on the board and we wish her the very best," stated Dr. Albert Friesen, chief executive officer and chair of Medicure's board of directors.

Conference call info:

Topic:  Medicure's Q3 2024 results

Call date:  Tuesday, Nov. 26, 2024

Time:  7:30 a.m. Central Time (8:30 a.m. Eastern Time)

Toll-free:  1-888-506-0062

International:  1-973-528-0011

Participant access code:   769525

Webcast:  This conference call will be webcast live over the Internet.

You may request international country-specific access information by e-mailing the company in advance. Management will accept and answer questions related to the financial results and operations during the question-and-answer period at the end of the conference call. A recording of the call will be available following the event at the company's website.

About Medicure Inc.

Medicure is a company focused on the development and commercialization of pharmaceuticals and health care products for patients and prescribers in the United States market. The present focus of the company is the marketing and distribution of Aggrastat (tirofiban hydrochloride) injection and Zypitamag (pitavastatin) tablets in the United States, where they are sold through the company's U.S. subsidiary, Medicure Pharma Inc. Medicure also operates Marley Drug Inc., a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans together with exceptional customer service and free home delivery.

We seek Safe Harbor.